BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 14563313)

  • 1. Induction of somatic hypermutation is associated with modifications in immunoglobulin variable region chromatin.
    Woo CJ; Martin A; Scharff MD
    Immunity; 2003 Oct; 19(4):479-89. PubMed ID: 14563313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Dot1L and H3K79 methylation in regulating somatic hypermutation of immunoglobulin genes.
    Duan Z; Baughn LB; Wang X; Zhang Y; Gupta V; MacCarthy T; Scharff MD; Yu G
    Proc Natl Acad Sci U S A; 2021 Jul; 118(29):. PubMed ID: 34253616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of HIRA-dependent H3.3 deposition and its modifications in the somatic hypermutation of immunoglobulin variable regions.
    Yu G; Zhang Y; Gupta V; Zhang J; MacCarthy T; Duan Z; Scharff MD
    Proc Natl Acad Sci U S A; 2021 Dec; 118(50):. PubMed ID: 34873043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone modifications associated with somatic hypermutation.
    Odegard VH; Kim ST; Anderson SM; Shlomchik MJ; Schatz DG
    Immunity; 2005 Jul; 23(1):101-10. PubMed ID: 16039583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ongoing somatic hypermutation of the rearranged VH but not of the V-lambda gene in EBV-transformed rheumatoid factor-producing lymphoblastoid cell line.
    Chezar I; Lobel-Lavi L; Steinitz M; Laskov R
    Mol Immunol; 2008 Nov; 46(1):80-90. PubMed ID: 18718665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isotype-switched follicular lymphoma displays dissociation between activation-induced cytidine deaminase expression and somatic hypermutation.
    Scherer F; Navarrete MA; Bertinetti-Lapatki C; Boehm J; Schmitt-Graeff A; Veelken H
    Leuk Lymphoma; 2016; 57(1):151-60. PubMed ID: 25860234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ATM is not required in somatic hypermutation of VH, but is involved in the introduction of mutations in the switch mu region.
    Pan-Hammarström Q; Dai S; Zhao Y; van Dijk-Härd IF; Gatti RA; Børresen-Dale AL; Hammarström L
    J Immunol; 2003 Apr; 170(7):3707-16. PubMed ID: 12646636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of DNA polymerase beta accompanies somatic hypermutation in human BL2 cell lines.
    Poltoratsky V; Prasad R; Horton JK; Wilson SH
    DNA Repair (Amst); 2007 Feb; 6(2):244-53. PubMed ID: 17127106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imprint of somatic hypermutation differs in human immunoglobulin heavy and lambda chain variable gene segments.
    Boursier L; Su W; Spencer J
    Mol Immunol; 2003 Jun; 39(16):1025-34. PubMed ID: 12749909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SRSF1-3, a splicing and somatic hypermutation regulator, controls transcription of IgV genes via chromatin regulators SATB2, UBN1 and histone variant H3.3.
    Singh AK; Tamrakar A; Jaiswal A; Kanayama N; Kodgire P
    Mol Immunol; 2020 Mar; 119():69-82. PubMed ID: 31986311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic hypermutation in 5' flanking regions of heavy chain antibody variable regions.
    Rothenfluh HS; Taylor L; Bothwell AL; Both GW; Steele EJ
    Eur J Immunol; 1993 Sep; 23(9):2152-9. PubMed ID: 8370398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What do somatic hypermutation and class switch recombination teach us about chronic lymphocytic leukaemia pathogenesis?
    Oppezzo P; Dighiero G
    Curr Top Microbiol Immunol; 2005; 294():71-89. PubMed ID: 16323428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The absence of DNA polymerase kappa does not affect somatic hypermutation of the mouse immunoglobulin heavy chain gene.
    Shimizu T; Shinkai Y; Ogi T; Ohmori H; Azuma T
    Immunol Lett; 2003 May; 86(3):265-70. PubMed ID: 12706529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible contribution of DNase gamma to immunoglobulin V gene diversification.
    Okamoto N; Okamoto M; Araki S; Arakawa H; Mizuta R; Kitamura D
    Immunol Lett; 2009 Jun; 125(1):22-30. PubMed ID: 19501119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Somatic hypermutation of the AID transgene in B and non-B cells.
    Martin A; Scharff MD
    Proc Natl Acad Sci U S A; 2002 Sep; 99(19):12304-8. PubMed ID: 12202747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Model of Somatic Hypermutation Targeting in Mice Based on High-Throughput Ig Sequencing Data.
    Cui A; Di Niro R; Vander Heiden JA; Briggs AW; Adams K; Gilbert T; O'Connor KC; Vigneault F; Shlomchik MJ; Kleinstein SH
    J Immunol; 2016 Nov; 197(9):3566-3574. PubMed ID: 27707999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uncoupling between Ig somatic hypermutation and oncogene mutation in mouse lymphoma.
    Vincent C; Truffinet V; Fiancette R; Petit B; Cogné N; Cogné M; Denizot Y
    Biochim Biophys Acta; 2009 Feb; 1793(2):418-26. PubMed ID: 19026697
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why does somatic hypermutation by AID require transcription of its target genes?
    Storb U
    Adv Immunol; 2014; 122():253-77. PubMed ID: 24507160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strand-biased spreading of mutations during somatic hypermutation.
    Unniraman S; Schatz DG
    Science; 2007 Aug; 317(5842):1227-30. PubMed ID: 17761884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of error-prone polymerases in BL2 cells activated for Ig somatic hypermutation.
    Poltoratsky V; Woo CJ; Tippin B; Martin A; Goodman MF; Scharff MD
    Proc Natl Acad Sci U S A; 2001 Jul; 98(14):7976-81. PubMed ID: 11427727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.